J R Jasper - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

J R Jasper

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

The Journal of Pharmacology and Experimental Therapeutics|February 25, 2000

Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzymeR Raddatz, S L Savic, V Bakthavachalam, et al.

British Journal of Pharmacology|April 27, 1999

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic miceQ M Zhu, J D Lesnick, J R Jasper, et al.

British Journal of Pharmacology|July 1, 1997

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classificationA P Ford, D V Daniels, D J Chang, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effectsD K Rohrer, K H Desai, J R Jasper, et al.

British Journal of Pharmacology|January 8, 1998

Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic miceJ C Hunter, D J Fontana, L R Hedley, et al.

Biochemical Pharmacology|May 30, 1998

Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS bindingJ R Jasper, J D Lesnick, L K Chang, et al.

Advances in Experimental Medicine and Biology|January 1, 1995

Progress in the development of oxytocin antagonists for use in preterm laborD J Pettibone, M Guidotti, C M Harrell, et al.

European Journal of Pharmacology|May 20, 1999

Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studiesD V Daniels, J R Gever, J R Jasper, et al.

FEBS Letters|March 7, 1998

Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoformsD J Chang, T K Chang, S S Yamanishi, et al.

Bioorganic & Medicinal Chemistry Letters|May 17, 2003

Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonistsF J Lopez, L Arias, R Chan, et al.

Pageof 3

Search research articles

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

The Journal of Pharmacology and Experimental Therapeutics|February 25, 2000

Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzymeR Raddatz, S L Savic, V Bakthavachalam, et al.

British Journal of Pharmacology|April 27, 1999

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic miceQ M Zhu, J D Lesnick, J R Jasper, et al.

British Journal of Pharmacology|July 1, 1997

Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classificationA P Ford, D V Daniels, D J Chang, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effectsD K Rohrer, K H Desai, J R Jasper, et al.

British Journal of Pharmacology|January 8, 1998

Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic miceJ C Hunter, D J Fontana, L R Hedley, et al.

Biochemical Pharmacology|May 30, 1998

Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS bindingJ R Jasper, J D Lesnick, L K Chang, et al.

Advances in Experimental Medicine and Biology|January 1, 1995

Progress in the development of oxytocin antagonists for use in preterm laborD J Pettibone, M Guidotti, C M Harrell, et al.

European Journal of Pharmacology|May 20, 1999

Human cloned alpha1A-adrenoceptor isoforms display alpha1L-adrenoceptor pharmacology in functional studiesD V Daniels, J R Gever, J R Jasper, et al.

FEBS Letters|March 7, 1998

Molecular cloning, genomic characterization and expression of novel human alpha1A-adrenoceptor isoformsD J Chang, T K Chang, S S Yamanishi, et al.

Bioorganic & Medicinal Chemistry Letters|May 17, 2003

Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonistsF J Lopez, L Arias, R Chan, et al.

Pageof 3